MCR Therapeutics will develop peptides to stimulate the production of melanin, a pigment which shields humans against ultraviolet rays and skin cancer.

DheeYantra has raised an undisclosed sum from investors including Indian Institute of Management Ahmedabad to build out its NLP software for native Indian vernaculars.

The newly-launched UCLA spinout is targeting rare and treatment-resistant forms of epilepsy with an approach drawing on certain kinds of gut bacteria.

Newly-launched ULB oncology spinout Epics Therapeutics will aim to develop drugs targeting malignant epigenetic RNA modifications.

Quantum computing spinout Zapata has emerged from stealth with a $5.4m seed round from investors including the Engine.

The round, which takes Indee's equity total to $3.9m, featured Main Sequence Ventures.